IMP: 2025 Annual Report
Filed with HOSE ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Imexpharm
- IMP: Record date for 2025 cash dividend payment
- IMP: Notice of the record date for 2025 cash dividend payment
- IMP: Approval of the record date for 2025 cash dividend payment
- IMP: Change in personnel
- IMP: Signing an audit contract for the 2026 financial statements
Later from Imexpharm
- IMP: Report on Corporate Governance for the first half of 2026
- IMP: The Board resolution dated September 7, 2026
- IMP: Update Regulations on Supervision and Approval of related party transactions
- IMP: Update Regulations on the Internal Audit
- IMP: Update Regulations on the Operation of the audit & Risk Management Committee
Follow Imexpharm into a list and get an email when it puts out news.
Follow Imexpharm